ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the American Society for Radiation Oncology (ASTRO) 2018 conference.
Radiation Oncology
Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.
-
-
Fujifilm's first FDA-cleared computed tomography (CT) system, the FCT Embrace, at the ...
-
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018.
-
An interview with A. M. Niser Syed, M.D., medical director, radiation oncology and endocurietherapy, MemorialCare Cancer Institute, Long Beach, Calif.
-
Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St.
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the...
Laurent Levy, CEO of Nanobiotix, explains the use of his company's nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment.
Blog | ASTRO | November 08, 2018 | Dave Fornell, Editor
Here are a few of the radiation oncology technology advancement takeaways seen at the 2018...
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Videos | Radiation Oncology | November 07, 2018
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.
Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation...
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more...
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.
Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American...
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
November 1, 2018 — The NRG Oncology ...
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
October 31, 2018 — An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized...
News | Treatment Planning | October 31, 2018
October 31, 2018 — Medical imaging software company Mirada Medical showcased its DLCExpert at the recent American...
News | Brachytherapy Systems | October 31, 2018
October 31, 2018 — A new analysis of nearly 600 men receiving...
Elekta SmartClinic is one of the key features in the Mosaiq Plaza suite of data-focused integrative oncology software
News | Radiation Therapy | October 30, 2018
October 30, 2018 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio...
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.
News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to...
